{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:21:32Z","timestamp":1791976892539,"version":"4.4.0"},"reference-count":32,"publisher":"Impact Journals, LLC","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,5,31]]},"DOI":"10.18632\/oncotarget.8655","type":"journal-article","created":{"date-parts":[[2016,4,9]],"date-time":"2016-04-09T03:17:29Z","timestamp":1460171849000},"page":"32462-32477","source":"Crossref","is-referenced-by-count":161,"title":["Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells"],"prefix":"10.18632","volume":"7","author":[{"given":"Paloma","family":"Guillem-Llobat","sequence":"first","affiliation":[{"name":"Department of Neuroscience, Imaging and Clinical Science, Section of Cardiovascular and Pharmacological Sciences, and CeSI-MeT, \u201cG. d'Annunzio\u201d University, School of Medicine, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melania","family":"Dovizio","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Imaging and Clinical Science, Section of Cardiovascular and Pharmacological Sciences, and CeSI-MeT, \u201cG. d'Annunzio\u201d University, School of Medicine, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Bruno","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Imaging and Clinical Science, Section of Cardiovascular and Pharmacological Sciences, and CeSI-MeT, \u201cG. d'Annunzio\u201d University, School of Medicine, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Ricciotti","sequence":"additional","affiliation":[{"name":"Institute for Translational Medicine and Therapeutics, University of Pennsylvania, School of Medicine, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Cufino","sequence":"additional","affiliation":[{"name":"Institute of General Pathology, Catholic University School of Medicine, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Sacco","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Imaging and Clinical Science, Section of Cardiovascular and Pharmacological Sciences, and CeSI-MeT, \u201cG. d'Annunzio\u201d University, School of Medicine, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalia","family":"Grande","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Imaging and Clinical Science, Section of Cardiovascular and Pharmacological Sciences, and CeSI-MeT, \u201cG. d'Annunzio\u201d University, School of Medicine, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Alberti","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Imaging and Clinical Science, Section of Cardiovascular and Pharmacological Sciences, and CeSI-MeT, \u201cG. d'Annunzio\u201d University, School of Medicine, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Arena","sequence":"additional","affiliation":[{"name":"Institute of Pathologic Anatomy, Catholic University, School of Medicine, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Cirillo","sequence":"additional","affiliation":[{"name":"Institute of Pathologic Anatomy, Catholic University, School of Medicine, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Patrono","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology, Catholic University, School of Medicine, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garret A.","family":"FitzGerald","sequence":"additional","affiliation":[{"name":"Institute for Translational Medicine and Therapeutics, University of Pennsylvania, School of Medicine, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Steinhilber","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Chemistry, Goethe University, Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sgambato","sequence":"additional","affiliation":[{"name":"Institute of General Pathology, Catholic University School of Medicine, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Patrignani","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Imaging and Clinical Science, Section of Cardiovascular and Pharmacological Sciences, and CeSI-MeT, \u201cG. d'Annunzio\u201d University, School of Medicine, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,4,8]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Weinberg","year":"2009","journal-title":"J Clin Invest"},{"key":"2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc2620","article-title":"Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits","volume":"9","author":"Weinberg","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2010.04131.x","article-title":"The platelet contribution to cancer progression","volume":"9","author":"Holmes","year":"2011","journal-title":"J Thromb Haemost"},{"key":"4","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","article-title":"Direct signalling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis","volume":"20","author":"Hynes","year":"2011","journal-title":"Cancer Cell"},{"key":"5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1124\/mol.113.084988","article-title":"Pharmacological inhibition of platelet-tumorcell cross-talk prevents platelet-induced overexpression of cyclooxygenase-2 in HT29 human colon carcinoma cells","volume":"84","author":"Patrignani","year":"2013","journal-title":"Mol Pharmacol"},{"key":"6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3004","article-title":"Contribution of platelets to tumour metastasis","volume":"11","author":"Felding-Habermann","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"7","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","article-title":"Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials","volume":"379","author":"Meade","year":"2012","journal-title":"Lancet"},{"key":"8","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","article-title":"Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials","volume":"379","author":"Mehta","year":"2012","journal-title":"Lancet"},{"key":"9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(97)11475-1","article-title":"Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk","volume":"351","author":"Meade","year":"1998","journal-title":"Lancet"},{"key":"10","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199110173251605","article-title":"Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin","volume":"325","author":"FitzGerald","year":"1991","journal-title":"N Engl J Med"},{"key":"11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1182\/blood-2014-03-562538","article-title":"Paraneoplastic thrombocytosis: the secrets of tumor self-promotion","volume":"124","author":"Schafer","year":"2014","journal-title":"Blood"},{"key":"12","first-page":"62","article-title":"Advances in antiplatelet therapy","volume":"2011","author":"Michelson","year":"2011","journal-title":"Hematology Am SocHematolEduc Program"},{"key":"13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/CRD.0b013e3182099d86","article-title":"Ticagrelor: a novel reversible oral antiplatelet agent","volume":"19","author":"Clark","year":"2011","journal-title":"Cardiol Rev"},{"key":"14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1021\/cb8002094","article-title":"Antagonists of the EP3 receptor for prostaglandin E2 are novel antiplatelet agents that do not prolong bleeding","volume":"4","author":"Sigthorsson","year":"2009","journal-title":"ACS Chem Biol"},{"key":"15","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0049-3848(87)90103-4","article-title":"Paired analysis of urinary thromboxane B2 metabolites in humans","volume":"47","author":"FitzGerald","year":"1987","journal-title":"Thromb Res"},{"key":"16","first-page":"723419","article-title":"Prostaglandins in cancer cell adhesion, migration, and invasion","volume":"2012","author":"Dubois","year":"2012","journal-title":"Int J Cell Biol"},{"key":"17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1158\/1940-6207.CAPR-13-0153","article-title":"Urinary PGE-M: A Promising Cancer Biomarker","volume":"6","author":"DuBois","year":"2013","journal-title":"Cancer prevention research"},{"key":"18","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Ahmad","year":"2008","journal-title":"FASEB J"},{"key":"19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0049-3848(80)90066-3","article-title":"Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects","volume":"17","author":"Peskar","year":"1980","journal-title":"Thromb Res"},{"key":"20","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cell.2004.06.006","article-title":"Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis","volume":"117","author":"Weinberg","year":"2004","journal-title":"Cell"},{"key":"21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbrc.2007.11.151","article-title":"Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer","volume":"367","author":"Raman","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"22","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1021\/jm950454k","article-title":"Aminoacetyl moiety as a potential surrogate for diacylhydrazine group of SC-51089, a potent PGE2 antagonist, and its analogs","volume":"39","author":"Savage","year":"1996","journal-title":"J Med Chem"},{"key":"23","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1111\/j.1476-5381.2011.01495.x","article-title":"andcharacterization of PF-04418948, a novel, potent and selective prostaglandin EP2 receptor antagonist","volume":"164","author":"Pullen","year":"2011","journal-title":"Br J Pharmacol"},{"key":"24","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1016\/j.yexcr.2007.06.004","article-title":"The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells","volume":"313","author":"Nelson","year":"2007","journal-title":"Exp Cell Res"},{"key":"25","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/ncb2455","article-title":"RAC1 activation mediates Twist1-induced cancer cell migration","volume":"14","author":"Yang","year":"2012","journal-title":"Nat Cell Biol"},{"key":"26","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1172\/JCI10881","article-title":"Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation","volume":"107","author":"Koller","year":"2001","journal-title":"J Clin Invest"},{"key":"27","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1182\/blood-2009-10-247296","article-title":"Deadly allies: the fatal interplay between platelets and metastasizing cancer cells","volume":"115","author":"Sch\u00f6n","year":"2010","journal-title":"Blood"},{"key":"28","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1349-7006.2012.02200.x","article-title":"Thromboxane Areceptor signaling facilitates tumor colonization through P-selectin-mediated interaction of tumor cells with platelets and endothelial cells","volume":"103","author":"Majima","year":"2012","journal-title":"Cancer Sci"},{"key":"29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/bbrc.1999.1840","article-title":"Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis","volume":"267","author":"Honn","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.plefa.2004.10.006","article-title":"Platelet activation in patients with colorectal cancer","volume":"72","author":"Patrignani","year":"2005","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"31","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","article-title":"NOD\/SCID\/\u03b3c null mouse: An excellent recipient mouse model for engraftment of human cells","volume":"100","author":"Nakahata","year":"2002","journal-title":"Blood"},{"key":"32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0076-6879(07)33003-6","article-title":"Noninvasive assessment of the role of cyclooxygenases in cardiovascular health: a detailed HPLC\/MS\/MS method","volume":"433","author":"FitzGerald","year":"2007","journal-title":"Methods Enzymol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8655","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T20:44:25Z","timestamp":1589229865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,8]]},"references-count":32,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2016,5,31]]}},"alternative-id":["8655","27074574"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.8655","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,8]]}}}